Unusual implantation site of a port-a-cath system via the right femoral vein.
Meyer
Frank
F
Department of Surgery, University Hospital, Otto von Guericke University Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, Germany. Frank.Meyer@Medizin.Uni-Magdeburg.de
Buerger
Thomas
T
Gebauer
Thomas
T
Halloul
Zuhir
Z
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000627:therapeutic use; D002330:Carmustine / Q000008:administration & dosage; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D016393:Lymphoma, B-Cell / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D008479:Mediastinal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy; D008558:Melphalan / Q000008:administration & dosage; D011034:Podophyllotoxin / Q000008:administration & dosage; D011859:Radiography; D013927:Thrombosis / Q000209:etiology; D014182:Transplantation, Autologous
D003561:Cytarabine; D011034:Podophyllotoxin; D008558:Melphalan; D002330:Carmustine